Aspirin CVD Indication On OTC Labeling Urged By FDA’s Jenkins
This article was originally published in The Tan Sheet
Executive Summary
A cardiovascular disease prevention indication on OTC aspirin could be on the horizon, particularly if industry heeds FDA's invitation to propose such a change to the internal analgesics monograph
You may also be interested in...
Drug Manufacturer Interest In Rx-To-OTC Pipeline Growing – FDA’s Ganley
FDA is seeing increased activity from drug companies wanting to switch their prescription drug products over-the-counter, according to Center for Drug Evaluation & Research OTC Drug Products Division Director Charles Ganley, MD
Drug Manufacturer Interest In Rx-To-OTC Pipeline Growing – FDA’s Ganley
FDA is seeing increased activity from drug companies wanting to switch their prescription drug products over-the-counter, according to Center for Drug Evaluation & Research OTC Drug Products Division Director Charles Ganley, MD
Drug Manufacturer Interest In Rx-To-OTC Pipeline Growing – FDA’s Ganley
FDA is seeing increased activity from drug companies wanting to switch their prescription drug products over-the-counter, according to Center for Drug Evaluation & Research OTC Drug Products Division Director Charles Ganley, MD